Back to Search
Start Over
Maintenance Therapy in the Treatment of Recurrent Epithelial Ovarian Cancer.
- Source :
-
Clinical Obstetrics & Gynecology . Mar2020, Vol. 63 Issue 1, p86-91. 6p. - Publication Year :
- 2020
-
Abstract
- A diagnosis of recurrent epithelial ovarian cancer carries with it a very poor prognosis despite aggressive chemotherapy with or without secondary surgical cytoreduction. Recently, maintenance treatment after second-line chemotherapy has gained momentum given promising results of antiangiogenics and PARP inhibitors used in this setting. When used appropriately, these agents may provide a meaningful survival benefit with minimal effects on quality of life. This paper reveals the current literature evaluating the use of maintenance therapy in the recurrent setting for the epithelial ovarian, fallopian tube, or primary peritoneal cancers. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 00099201
- Volume :
- 63
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Clinical Obstetrics & Gynecology
- Publication Type :
- Academic Journal
- Accession number :
- 141365368
- Full Text :
- https://doi.org/10.1097/GRF.0000000000000500